Clinical trial
Ginger's Therapeutic Potential in Asthma - Phase 2a
NCT07792395 is registered in ClinicalTrials.gov with Emily DiMango, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ginger's Therapeutic Potential in Asthma - Phase 2a
- Lead sponsor
- Emily DiMango, MD
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- November 30, 2026
- Completion date
- March 31, 2029
- Enrollment
- 32 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.